
Sign up to save your podcasts
Or


Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.
By The Economist4.5
24022,402 ratings
Pharmaceutical giant AstraZeneca has paused a £200m investment in Britain and could move its primary listing to America. Can the UK maintain its status as a “life-science superpower”? Why autonomous air wings are the future of war in the sky. And how scientists in the Caribbean are restoring the barrier reef through “coral IVF”.
Listen to what matters most, from global politics and business to science and technology—Subscribe to Economist Podcasts+
For more information about how to access Economist Podcasts+, please visit our FAQs page or watch our video explaining how to link your account.
Hosted on Acast. See acast.com/privacy for more information.

7,663 Listeners

4,158 Listeners

921 Listeners

1,799 Listeners

587 Listeners

364 Listeners

97 Listeners

107 Listeners

637 Listeners

985 Listeners

225 Listeners

46 Listeners

1,081 Listeners

1,410 Listeners

136 Listeners

115 Listeners

102 Listeners

37 Listeners

457 Listeners

891 Listeners

371 Listeners

498 Listeners

79 Listeners

183 Listeners

147 Listeners

73 Listeners

100 Listeners

264 Listeners